Meinian Onehealth reports strong Q3 2025 growth, strategic acquisitions

Meinian Onehealth Healthcare Holdings (SZSE:002044) announced a strong third quarter for 2025, with net profit attributable to shareholders increasing by 13.65% to 273.2m yuan. For the first nine months of 2025, net profit surged by 110.53% year-over-year to 51.8m yuan, despite a 3.01% decrease in operating revenue to 6.9bn yuan for the same period.

The board of directors approved the Q3 2025 report on October 30, 2025. Key operational highlights included an increase in customer payments via notes, leading to a 246.90% rise in accounts receivable notes to 8.6m yuan. The company also saw significant growth in AI-driven services, with revenues from these technologies increasing by 71.02% to 24,963.84 yuan for the first nine months.

Furthermore, Meinian Onehealth is actively pursuing strategic acquisitions, as evidenced by shareholder approval on July 28, 2025, to acquire stakes in 11 companies through stock issuance. This initiative is pending regulatory approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission.